(Q38945524)

English

Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Alberto Ballestrero

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Francesco Grossi

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Francesco Grossi

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Maria Giovanna Dal Bello

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Roberta Venè

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Anna Garuti

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Enrico Carminati

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Erika Rijavec

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Giulia Barletta

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Claudio Sini

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Francesco Boccardo

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

25 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Targeted oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

393-404

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Epithelial-mesenchymal transitions in tumour progression

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC.

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Afatinib for the treatment of advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Afatinib: first global approval

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

The EGFR T790M mutation in acquired resistance to an irreversible second-generation EGFR inhibitor

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop.

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Protein kinase C: a target for anticancer drugs?

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

The activation of Akt/PKB signaling pathway and cell survival.

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

ICAM-3 endows anticancer drug resistance against microtubule-damaging agents via activation of the ICAM-3-AKT/ERK-CREB-2 pathway and blockage of apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Curcumin suppresses doxorubicin-induced epithelial-mesenchymal transition via the inhibition of TGF-β and PI3K/AKT signaling pathways in triple-negative breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0344-7

21 January 2018

Epithelial-mesenchymal transition in EGFR-TKI acquired resistant lung adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25341405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/25341405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A family of Shc related proteins with conserved PTB, CH1 and SH2 regions

1 reference

https://pubmed.ncbi.nlm.nih.gov/25341405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of 12-O-tetradecanoylphorbol-13-acetate on adhesiveness and lung-colonizing ability of Lewis lung carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25341405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genomic aberrations associated with erlotinib resistance in non-small cell lung cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25341405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Not all Shc's roads lead to Ras

1 reference

https://pubmed.ncbi.nlm.nih.gov/25341405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11523-014-0344-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25341405%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38945524&oldid=2202348005"